DiscoverFirstTake on Pharma - Pharma News and Analysis PodcastThe First Take – Pfizer’s antiviral haul, BMS lays out a growth strategy and Biogen’s week to forget
The First Take – Pfizer’s antiviral haul, BMS lays out a growth strategy and Biogen’s week to forget

The First Take – Pfizer’s antiviral haul, BMS lays out a growth strategy and Biogen’s week to forget

Update: 2021-11-19
Share

Description

FirstWord Pharma PLUS editors Virginia Li, Michael Flanagan and Simon King discuss more developments in the race to bring COVID-19 antivirals to patients, Bristol Myers Squibb’s long term outlook and the pending departure of veteran Al Sandrock as Biogen’s head of R&D.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

The First Take – Pfizer’s antiviral haul, BMS lays out a growth strategy and Biogen’s week to forget

The First Take – Pfizer’s antiviral haul, BMS lays out a growth strategy and Biogen’s week to forget

FirstWord Pharma